Photodynamic Therapy

  • R. O. Plail
  • J. I. Harty
  • H. B. Lottmann
Part of the The Bloomsbury Series in Clinical Science book series (BLOOMSBURY)


Photodynamic therapy (PDT) is an experimental form of cancer treatment which has been used to treat a variety of human cancers including transitional cell carcinoma of the bladder (Dougherty 1986). A simplified scheme of the principles of PDT is shown in Fig. 6. 1.


Photodynamic Therapy Light Dose Superficial Bladder Cancer Copper Vapour Laser Photodynamic Effect 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Auler H, Banzer G (1942) Untersuchungen über die Rolle der Porphyrine bei geschwulstkranken Menschen und Tieren. Z Krebsforsch 53: 65–68CrossRefGoogle Scholar
  2. Baghdassarian R, Wright MW, Vaughn SA Berns MW, Martin DG, Wile AG (1985) The use of lipid emulsion as an intravesical medium to disperse light in the potential treatment of bladder tumours. J Urol 133: 126–130PubMedGoogle Scholar
  3. Barr H, Tralau CJ, Boulos PB et al. (1987a) The contrasting mechanisms of colonic collagen damage between photodynamic therapy and thermal injury. Photochem Photobiol 46: 795–800PubMedCrossRefGoogle Scholar
  4. Barr H, Tralau CJ, McRobert A et al. (1987b) Photodynamic therapy in the normal rat colon with phthalocyanine sensitisation. Br J Cancer 56: 111–118PubMedCrossRefGoogle Scholar
  5. Bellnier DA, Dougherty TJ (1982) Membrane lysis in Chinese hamster ovary cells with hematoporphyrin derivative plus light. Photochem Photobiol 36: 43–47PubMedCrossRefGoogle Scholar
  6. Ben-Hur E, Rosenthal I (1985) The phthalocyanines: a new class of mammalian cell photosensitizers with a potential for cancer phototherapy. Int J Radiat Biol 47: 145–147CrossRefGoogle Scholar
  7. Benson RC (1986) Integral photoradiation therapy of multifocal bladder tumors. Eur Urol 12 [Suppl 11: 47–53Google Scholar
  8. Berenbaum MC, Bonnett R, Scourides PA (1982) In vivo activity of the components of haematoporphyrin derivative. Br J Cancer 45: 571–581PubMedCrossRefGoogle Scholar
  9. Berenbaum MC Akande SL. Bonnett R et al. (1986a). Meso-tetra(hydroxyphenyl)porphyrins, a new class of potent tumour photosensitisers with favourable selectivity. Br J Cancer 54: 717–725CrossRefGoogle Scholar
  10. Berenbaum MC. Hall GW. Hoyes AD (1986b) Cerebral photosensitisation by haematoporphyrin derivative. Evidence for an endothelial site of action. Br J Cancer 53: 81–89Google Scholar
  11. Bonnett R. Berenbaum MC (1989) Porphyrins as photosensitising compounds: their chemistry. biology and clinical use. Wiley, Chichester (CIBA Foundation Symposium 146 ). pp 40–59Google Scholar
  12. Bonnett R, Ridge RJ, Scourides PA. Berenbaum MC (1981) On the nature of haematoporphyrin derivative. J Chem Soc [Perkin 1] 3135–3140Google Scholar
  13. Bown SG. Tralau CJ. Coleridge-Smith PD (1986) Photodynamic therapy with porphyrin and phthalocyanine sensitisation: quantitative studies in normal rat liver. Br J Cancer 5: 43–52CrossRefGoogle Scholar
  14. Bugelski PJ, Porter CW, Dougherty TJ (1981) Autoradiographic distribution of hematoporphyrin derivative in normal and tumour tissue of the mouse. Cancer Res 41: 4606–4612PubMedGoogle Scholar
  15. Diamond I. Granelli SG. McDonagh AF. Neilsen S. Wilson CB. Jaenicke R (1972) Photodynamic therapy of malignant tumours. Lancet ii: 1175–1177CrossRefGoogle Scholar
  16. Dougherty TJ (1984) Photodynamic therapy (PDT) of malignant tumours. CRC Crit Rev Oncol Hematol 2: 83–116CrossRefGoogle Scholar
  17. Dougherty TJ (1986) Photosensitization of malignant tumours. Semin Surg Oncol 2: 24–37PubMedCrossRefGoogle Scholar
  18. Dougherty TJ. Grindey GB. Fiel R. Weishaupt KR, Boyle DG (1975) Photoradiation therapy II. Cure of animal tumours with hematoporphyrin and light. J Natl Cancer Inst 55: 115–119Google Scholar
  19. Dougherty TJ. Potter WR. Weishaupt R (1984) The structure of the active component of HpD. In: Doiron DR. Gomer CJ (eds) Porphyrin localization and treatment of tumors. Alan R Liss. New York, pp 301–314 (Progress in clinical and biological research vol 170 )Google Scholar
  20. Foote CS (1984) Mechanisms of photooxygenation. In: Doiron DR. Gomer CJ (eds) Porphyrin localization and treatment of tumors. Alan R Liss, New York, pp 3–18 (Progress in clinical and biological research vol 170 )Google Scholar
  21. Glashan RW (1987) Assessment and treatment of superficial bladder tumours. In: Hendry WF (ed) Recent advances in urology and andrology vol 4. Churchill Livingstone. Edinburgh, pp 187–203Google Scholar
  22. Gomer CJ. Dougherty TJ (1979) Determination of [3H]- and [14C]-hematoporphyrin derivative distribution in malignant and normal tissue. Cancer Res 39: 146–151PubMedGoogle Scholar
  23. Gomer CJ. Razum NJ (1984) Acute skin response in albino mice following porphyrin photosensitisation under oxic and anoxic conditions. Photochem Photobiol 40: 435–439PubMedCrossRefGoogle Scholar
  24. Gomer CJ, Smith DM (1980) Photoinactivation of Chinese hamster cells by haematoporphyrin derivative and red light. Photochem Photobiol 32: 341–348PubMedCrossRefGoogle Scholar
  25. Gregorie HB. Horger EO, Ward JL et al. (1968) Hematoporphyrin derivative fluorescence in malignant neoplasms. Ann Surg 167: 820–828PubMedCrossRefGoogle Scholar
  26. Harty JI, Amin M, Wieman TJ et al. (1989) Complications of whole bladder dihematoporphyrin ether photodynamic therapy. J Urol 141: 1341–1346PubMedGoogle Scholar
  27. Henderson BW, Dougherty TJ. Malone PB (1984) Studies of the mechanism of tumour destruction by photoradiation therapy. In: Doiron DR, Gomer CJ (eds) Porphyrin localization and treatment of tumors. Alan R Liss, New York, pp 601–612 (Progress in clinical and biological research vol 170)Google Scholar
  28. Heney NM, Nocks BN, Daly JJ et al. (1982) Ta and T1 bladder carcinoma: location, recurrence and progression. Br J Urol 54: 152–157PubMedCrossRefGoogle Scholar
  29. Hisazumi H, Misaki T, Miyoshi N (1983) Photoradiation therapy of bladder tumours. J Urol 130: 685–687PubMedGoogle Scholar
  30. Hisazumi H, Miyoshi N, Naito K et al. (1984) Whole bladder wall photoradiation therapy for carcinoma in situ of the bladder: a preliminary report. J Urol 13: 884–887Google Scholar
  31. Jocham D, Staehler G. Chaussy Ch et al. (1984a) Integral dye-laser irradiation of photosensitised bladder tumours with the aid of a light scattering medium. In: Doiron DR, Gomer CJ (eds) Porphyrin localization and treatment of tumors. Alan R Liss, New York, pp 249–256 (Progress in clinical and biological research vol 170 )Google Scholar
  32. Jocham D, Staehler G, Unsold E, Chaussy C, Lohrs U (1984b) Dye laser photoradiation therapy of bladder cancer after photosensitization with haematoporphyrin derivative (HpD). Basis for an integral irradiation. In: Andreoni A. Cubeddu R (eds) Porphyrins in tumor phototherapy. Plenum Press, New York, pp 427–438Google Scholar
  33. Jocham D, Schmiedt E, Baumgartner R, Unsold E (1986) Integral laser-photodynamic treatment of multifocal bladder carcinoma photosensitized by hematoporphyrin derivative. Eur Urol 12 [Suppl l]: 43–46PubMedGoogle Scholar
  34. Kelly JF, Snell ME (1976) Hematoporphyrin derivative: a possible aid in the diagnosis and therapy of carcinoma of the bladder. J Urol 115: 150–151PubMedGoogle Scholar
  35. Kelly JF, Snell ME, Berenbaum MC (1975) Photodynamic destruction of human bladder carcinoma. Br J Cancer 31: 237–245PubMedCrossRefGoogle Scholar
  36. Kessel D (1986) Proposed structure of the tumour-localizing fraction of HpD (hematoporphyrin derivative). Photochem Photobiol 44: 193–196PubMedCrossRefGoogle Scholar
  37. Kessel D, Dutton CJ (1984) Photodynamic effects: porphyrin vs. chlorin. Photochem Photobiol 40: 403–405PubMedCrossRefGoogle Scholar
  38. Lin C, Bellnier DA, Fujime M, Prout GR (1984) HpD photodetection of bladder carcinoma. In: Doiron DR, Gomer CJ (eds) Porphyrin localization and treatment of tumors. Alan R Liss, New York, pp 187–199 (Progress in clinical and biological research vol 170 )Google Scholar
  39. Lipson RL, Baldes EJ, Olsen AM (1961) The use of a derivative of hematoporphyrin in tumour detection. J Natl Cancer Inst 26: 1–11PubMedGoogle Scholar
  40. Lipson RL, Gray MJ, Baldes EJ (1967) Hematoporphyrin derivative for detection and management of cancer. In: Harris RCJ (ed) Proceedings of the ninth international cancer congress. Springer, Berlin Heidelberg New YorkGoogle Scholar
  41. Lottmann H (1987) These Médecin, ParisGoogle Scholar
  42. Lottmann H, Harty JI, Tralau CJ, Bown SG (1988) The effect of photodynamic therapy with phthalocyanine sensitization on the strength and compliance of the normal rat bladder. Paper presented at the sixth annual meeting of the British Medical Laser Association. LondonGoogle Scholar
  43. Malik Z, Djaldetti M (1980) Destruction of erythroleukaemia, myelocytic leukaemia and Burkitt lymphoma cells by photoactivated protoporphyrin. Int J Cancer 26: 495–500PubMedCrossRefGoogle Scholar
  44. Mang TS, Dougherty TJ, Potter WR, Boyle DG, Somer S, Moan J (1987) Photobleaching of porphyrin used in photodynamic therapy and implications for therapy. Photochem Photobiol 45: 501–506PubMedCrossRefGoogle Scholar
  45. Moan J (1986) Porphyrin-sensitized photodynamic inactivation of cells: a review. Lasers Med Sci 1: 5–12CrossRefGoogle Scholar
  46. Nseyo UO, Dougherty TJ, Boyle DG et al. (1985) Experimental photodynamic treatment of canine bladder. J Urol 133: 311–315PubMedGoogle Scholar
  47. Nseyo UO, Dougherty TJ, Sullivan L (1987) Experimental photodynamic treatment of resistant lower urinary tract carcinoma. Cancer 60: 3113–3119PubMedCrossRefGoogle Scholar
  48. Ohi T, Kato H, Tsuchiya A (1984) Photoradiation therapy with hematoporphyrin derivative and an argon dye laser of bladder carcinoma. In: Adreoni A, Cubeddu R (eds) Porphyrins in tumor phototherapy. Plenum Press, New York, pp 439–446Google Scholar
  49. OPCS (1988) Cancer statistics registrations. Cases of diagnosed cancer registered in England and Wales 1984. HMSO, London (Office of Population Censuses and Surveys series MB1, no 16)Google Scholar
  50. Plail RO, Berenbaum MC, Snell MS (1988) Histological effects of photodynamic therapy on normal and neoplastic rat bladder sensitized with haematoporphyrin derivative and treated with light at 511 and 578 nm. Paper presented at the British Association of Urological Surgeons annual meeting, Buxton, June 1988Google Scholar
  51. Policard A (1924) Etude sur les aspects offerts par des tumeurs éxperimentales examinées à la luminere de Wood. C R Soc Biol (Paris) 91: 1423–1424Google Scholar
  52. Potter WR, Mang TS, Dougherty TJ (1987) The theory of photodynamic dosimetry: consequences of photodestruction of the sensitizer. Photochem Photobiol 46: 97–101PubMedCrossRefGoogle Scholar
  53. Prout GJ Jr, Lin C, Benson RC Jr et al. (1987) Photodynamic therapy with hematoporphyrin derivative in the treatment of superficial transitional cell carcinoma of the bladder. N Engl J Med 317: 1251–1255PubMedCrossRefGoogle Scholar
  54. Raab O (1900) Ueber die Wirkung fluoreszierender Stoffe auf Influsorein. Z Biol 39: 524–546Google Scholar
  55. Selman SH, Kreimer-Birnbaum M, Klaunig JE, Goldblatt PJ, Keck RW, Britton SL (1984) Blood flow in transplantable bladder tumours treated with hematoporphyrin derivative and light. Cancer Res 44: 1924–1927PubMedGoogle Scholar
  56. Selman SH, Goldblatt PJ, Klaunig JE, Keck RW, Kreimer-Birnbaum M (1985) Localisation of hematoporphyrin derivative in injured bladder mucosa. An experimental study. J Urol 133: 1104–1107Google Scholar
  57. Severs NJ, Barnes SH, Wright R, Hicks RM (1982) Induction of bladder cancer in rats by fractionated intravesicular doses of N-methyl-N-nitrosurea. B J Cancer 45: 337–351CrossRefGoogle Scholar
  58. Shumaker PB, Hetzel FW (1987) Clinical laser photodynamic therapy in the treatment of bladder carcinoma. Photochem Photobiol 46: 899–909PubMedCrossRefGoogle Scholar
  59. Spikes JD (1984) Photobiology of porphyrins. In: Doiron DR, Gomer CJ (eds) Porphyrin localization and treatment of tumours. Alan R Liss, New York, pp 19–39 (Progress in clinical and biological research vol 170 )Google Scholar
  60. Star WM, Marijnissen JPA van den Berg-Blok AE, Reinhold HS (1984) Destructive effect of photoradiation on the microcirculation of a rat mammary tumour growing in “sandwich” observation chambers. In: Doiron DR. Gomer CJ (eds) Porphyrin localization and treatment of tumors. Alan R Liss. pp 637–645 (Progress in clinical and biological research vol 170 )Google Scholar
  61. Star WM. Marijnissen HPA. Jansen H. Keijzer M. van Gemert MJC (1987) Light dosimetry for photodynamic therapy by whole bladder wall irradiation. Photochem. Photobiol 46: 619–624Google Scholar
  62. Svaasand L (1985) Photodynamic and photohvperthermic response of malignant tumours. Med Phys 12: 455–461PubMedCrossRefGoogle Scholar
  63. Tappeiner H. Jesionek A (1903) Therapeutische Versuche mit fluoreszierenden Stoffen. MWWR 2: 2040–2044Google Scholar
  64. Tsuchiya A, Obara N. Miwa M. Ohi T. Kato H. Hayata Y (1983) Hematoporphyrin derivative and laser photoradiation in the diagnosis and treatment of bladder cancer. J Urol 130: 79–82PubMedGoogle Scholar
  65. van Gemert JC. Berenbaum MC, Gijsbers GHM (1985) Wavelength and light-dose dependence in tumour phototherapy with hematoporphyrin derivative. Br J Cancer 52: 43–49PubMedCrossRefGoogle Scholar
  66. van Lier JE (1988) New sensitizers for photodvnamic therapy of cancer. Light in Biology and Medicine 1: 133–141CrossRefGoogle Scholar
  67. Weishaupt KR, Gomer CL. Dougherty TJ (1976) Identification of singlet oxygen as the cytotoxic agent in photoinactivation of a murine tumour. Cancer Res 36:2326–2329 PubMedGoogle Scholar
  68. Williams JL, Stamp J (1988) Photodynamic therapy in the treatment of multiple superficial tumours of the bladder. Presentation at the British Association of Urological Surgeons annual meeting, Buxton. June 1988Google Scholar

Copyright information

© Springer-Verlag London Limited 1990

Authors and Affiliations

  • R. O. Plail
  • J. I. Harty
  • H. B. Lottmann

There are no affiliations available

Personalised recommendations